You are here: Industry Insights > Johnson & Johnson

News List

Actelion announces changes to its executive team upon completion of the transaction with Johnson & J firstwordpharma
May 16, 2017
Actelion Ltd (SIX: ATLN) today announced changes to its executive team that would only take effect upon closing of the transaction with Johnson & Johnson expected towards the end of the second quarter 2017.
Here's How Much Johnson & Johnson Will Probably Raise Its Dividend Next Month fool
April 01, 2017
Johnson & Johnson Will Probably Raise Its Dividend Next Month.
Johnson & Johnson Innovation Launches Singapore QuickFire Challenge Competition in Collaboration wit en-cphi.cn
March 23, 2017
Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., announced today a collaboration with A*STAR's ETPL, through its Diagnostics Development Hub...
Johnson & Johnson, Bayer's Xarelto superior to aspirin for long-term prevention of recurrent blood c drugs.com
March 20, 2017
Results from the Phase III EINSTEIN CHOICE study presented at the American College of Cardiology (ACC) annual scientific session demonstrated that extended use of Johnson & Johnson and Bayer's anticoagulant Xarelto (rivaroxaban)...
Johnson & Johnson reports that investigational Ebola vaccine regimen induced durable immune response worldpharmanews
March 16, 2017
Johnson & Johnson announced that final Phase 1 clinical trial data published in JAMA:
Johnson & Johnson completes acquisition of Abbott Medical Optics worldpharmanews
March 02, 2017
Johnson & Johnson (NYSE: JNJ) has completed the acquisition of Abbott Medical Optics (AMO) a wholly-owned subsidiary of Abbott.
Johnson & Johnson Innovation’s Global Pursuit of Cutting-Edge Science Yields 15 New Collaborations, firstwordpharma
January 06, 2017
Collaborations advance novel research across pharmaceutical, medical device and consumer healthcare sectors, in areas including 3D printing, the microbiome and immunotherapy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page